FI944535A - Rapamysiinikoostumuksia oraalisesti annettaviksi - Google Patents

Rapamysiinikoostumuksia oraalisesti annettaviksi Download PDF

Info

Publication number
FI944535A
FI944535A FI944535A FI944535A FI944535A FI 944535 A FI944535 A FI 944535A FI 944535 A FI944535 A FI 944535A FI 944535 A FI944535 A FI 944535A FI 944535 A FI944535 A FI 944535A
Authority
FI
Finland
Prior art keywords
oral administration
volume
rapamycin
rapamycin compositions
compositions
Prior art date
Application number
FI944535A
Other languages
English (en)
Swedish (sv)
Other versions
FI944535A0 (fi
FI115033B (fi
Inventor
Robert Paul Waranis
Thomas Waymond Leonard
Maureen Murphy Harrison
Christian Luther Ofslager
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI944535A0 publication Critical patent/FI944535A0/fi
Publication of FI944535A publication Critical patent/FI944535A/fi
Application granted granted Critical
Publication of FI115033B publication Critical patent/FI115033B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI944535A 1993-09-30 1994-09-29 Menetelmä rapamysiinikoostumuksien valmistamiseksi oraalisesti annettaviksi FI115033B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12952393A 1993-09-30 1993-09-30
US12952993A 1993-09-30 1993-09-30
US12952993 1993-09-30
US12952393 1993-09-30

Publications (3)

Publication Number Publication Date
FI944535A0 FI944535A0 (fi) 1994-09-29
FI944535A true FI944535A (fi) 1995-03-31
FI115033B FI115033B (fi) 2005-02-28

Family

ID=26827648

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944535A FI115033B (fi) 1993-09-30 1994-09-29 Menetelmä rapamysiinikoostumuksien valmistamiseksi oraalisesti annettaviksi

Country Status (13)

Country Link
EP (1) EP0648494B1 (fi)
AT (1) ATE173628T1 (fi)
AU (1) AU688782B2 (fi)
DE (2) DE10199046I1 (fi)
DK (1) DK0648494T3 (fi)
ES (1) ES2124852T3 (fi)
FI (1) FI115033B (fi)
GR (1) GR3029439T3 (fi)
HK (1) HK1010342A1 (fi)
HU (1) HU220870B1 (fi)
LU (1) LU90832I2 (fi)
NL (1) NL300055I2 (fi)
SG (1) SG47803A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4336434A1 (de) * 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
PE52896A1 (es) * 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
GB2331924A (en) * 1997-12-08 1999-06-09 Phares Pharm Res Nv Lipid compositions and their use
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
AU773618B2 (en) * 1998-12-22 2004-05-27 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Water-insoluble drug delivery system
KR100956195B1 (ko) 2002-02-01 2010-05-06 어리어드 파마슈티칼스, 인코포레이티드 인 함유 화합물 및 이의 용도
WO2005110360A2 (en) * 2004-05-18 2005-11-24 Phares Pharmaceutical Research N.V. Compositions for injection
AU2007212271B2 (en) * 2006-02-09 2012-11-01 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
MX2016004530A (es) 2013-10-08 2017-02-13 Lam Therapeutics Inc Rapamicina para el tratamiento de linfangioleiomiomatosis.
CA2939342A1 (en) * 2014-02-11 2015-08-20 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
PL3125875T3 (pl) 2014-04-04 2023-11-20 AI Therapeutics, Inc. Nadający się do inhalacji preparat rapamycyny do leczenia stanów związanych z wiekiem
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543727B2 (en) * 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
GB9103430D0 (en) * 1991-02-19 1991-04-03 Smithkline Beecham Plc Novel compound
IL111003A0 (en) * 1993-09-30 1994-11-28 American Home Prod Multi-component oral rapamycin formulation

Also Published As

Publication number Publication date
NL300055I1 (nl) 2001-12-01
AU688782B2 (en) 1998-03-19
GR3029439T3 (en) 1999-05-28
ATE173628T1 (de) 1998-12-15
NL300055I2 (nl) 2002-04-02
DE69414810D1 (de) 1999-01-07
LU90832I2 (fr) 2001-11-12
SG47803A1 (en) 1998-04-17
HU9402786D0 (en) 1994-12-28
EP0648494B1 (en) 1998-11-25
FI944535A0 (fi) 1994-09-29
FI115033B (fi) 2005-02-28
DE10199046I1 (de) 2002-01-10
HU220870B1 (en) 2002-06-29
HUT71115A (en) 1995-11-28
AU7420594A (en) 1995-04-13
ES2124852T3 (es) 1999-02-16
EP0648494A1 (en) 1995-04-19
HK1010342A1 (en) 1999-06-17
DE69414810T2 (de) 1999-04-22
DK0648494T3 (da) 1999-08-09

Similar Documents

Publication Publication Date Title
CA2133175A1 (en) Rapamycin formulations for oral administration
CA2133177A1 (en) Rapamycin formulations for oral administration
FI944535A (fi) Rapamysiinikoostumuksia oraalisesti annettaviksi
FI935821A (fi) Taksaanijohdannaisten fosfonooksimetyyliestereitä
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
FI945619A0 (fi) Syklosporiinia sisältävät nestemäiset valmisteet ja menetelmä niiden valmistamiseksi
AU7026794A (en) Phosphonooxymethyl ethers of taxane derivatives
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
LU90155I2 (fr) Vistide - cidofovir 75 mg/ml
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
HUT68958A (en) Arylidene-1-azacycloalkane and aryl-alkyl-1-azacycloalkane derivatives their salts, pharmaceutical compositions containing them, and their preparation
FI934297A0 (fi) Fosfolipidderivat, innehaollande grundaemnen ur den femte huvudgruppen med ett hoegt ordingstal
IL103856A0 (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
FR2701477B1 (fr) Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
HU9402171D0 (en) Benzopyrane derivatives process for producing them, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115033

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20050020

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 263

Extension date: 20150926

MM Patent lapsed